standard radioimmunotherapy with 90-yttrium-labeled anti-CD20-antibodies in treatment of relapsed and/or refractory follicular NHL or partial remission after induction chemotherapy
finding of at least one image-guided measurable lymphoma lesion
existence of FDG-PET- and CT-image data of at most 8 weeks before treatment
signed patient´s agreement for RIT registry and MERIT-NHL
You may not be if
other therapy modalities than standard radioimmunotherapy (e.g. consolidation)
